ORGO Q3 2018 Earnings — Organogenesis Holdings Inc. Revenue & Financial Results | Market Cap Arena

ORGOOrganogenesis Holdings Inc.

$338M

Q3 2018 Earnings

Healthcare Drug Manufacturers - Specialty & Generic

Income Statement

Revenue

$0

Gross Profit

-$2M

Operating Income

-$2M

Net Income

$5M

EPS (Diluted)

$-0.19

QoQ Revenue Growth

NaN%

Cash Flow

Operating Cash Flow

-$286,706

Free Cash Flow

-$286,706

Stock-Based Comp.

$0

Balance Sheet

Total Assets

$316M

Total Liabilities

$13M

Stockholders' Equity

$303M

Cash & Equivalents

$2,705

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	-$2M	-$3M	+21.2%
Operating Income	-$2M	-$3M	+21.2%
Net Income	$5M	-$2M	+333.2%